Pathophysiology of Alzheimer’s Disease

The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657 · see citing works

Dementia prevention, intervention, and care

Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31363-6 · Cited by 6,072 · see citing works

What is cognitive reserve? Theory and research application of the reserve concept

STERN, Y. (2002) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617702813248 · Cited by 3,951 · see citing works

Cognitive reserve in ageing and Alzheimer's disease

Stern, Y. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70191-6 · Cited by 3,557 · see citing works

2022 Alzheimer's disease facts and figures

Anonymous (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12638 · Cited by 2,384 · see citing works

The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease

Hampel, H., Mesulam, M.-M., Cuello, A. C., Farlow, M. R., Giacobini, E., Grossberg, G. T., Khachaturian, A. S., Vergallo, A., Cavedo, E., Snyder, P. J., et al. (2018) · Brain · doi:10.1093/brain/awy132 · Cited by 1,918 · see citing works

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

Brookmeyer, R., Gray, S. G., & Kawas, C. H. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,774 · see citing works

Neuroinflammation in Alzheimer's disease: current evidence and future directions

Calsolaro, V., & Edison, P. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.02.010 · Cited by 1,726 · see citing works

Human ApoE isoforms differentially regulate brain amyloid-β peptide clearance

Castellano, J. M., Kim, J., Stewart, F. R., Jiang, H., DeMattos, R. B., Patterson, B. W., Fagan, A. M., Morris, J. C., Mawuenyega, K. G., Cruchaga, C., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002156 · Cited by 1,227 · see citing works

Neuropsychological Assessment

Braun, M., Tupper, D. E., Kaufmann, P., McCrea, M., Postal, K., Westerveld, M., Wills, K., & Deer, T. M. (2011) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0b013e3182351289 · Cited by 1,062 · see citing works

Alzheimer’s disease: risk factors and potentially protective measures

Silva, M. V. F., Loures, C. D. M. G., Alves, L. C. V., de Souza, L. C., Borges, K. B. G., & Ferriani, M. D. G. C. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0524-y · Cited by 962 · see citing works

Role of Cholinergic Signaling in Alzheimer’s Disease

Chen, Z.-R., Huang, J.-B., Yang, S.-L., & Hong, F.-F. (2022) · Molecules · doi:10.3390/molecules27061816 · Cited by 922 · see citing works

Brain reserve capacity on symptom onset after brain injury: A formulation and review of evidence for threshold theory.

Satz, P. (1993) · Neuropsychology · doi:10.1037/0894-4105.7.3.273 · Cited by 851 · see citing works

Verbal fluency performance in dementia of the Alzheimer’s type: a meta-analysis

Henry, J. D., Crawford, J. R., & Phillips, L. H. (2004) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2004.02.001 · Cited by 847 · see citing works

Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease

Khan, S., Barve, K. H., & Kumar, M. S. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200528142429 · Cited by 820 · see citing works

Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease

Reiman, E. M., Chen, K., Liu, X., Bandy, D., Yu, M., Lee, W., Ayutyanont, N., Keppler, J., Reeder, S. A., Langbaum, J. B. S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900345106 · Cited by 785 · see citing works

Global Epidemiology of Dementia: Alzheimer’s and Vascular Types

Rizzi, L., Rosset, I., & Roriz‐Cruz, M. (2014) · BioMed Research International · doi:10.1155/2014/908915 · Cited by 752 · see citing works

Chronic neuropathologies of single and repetitive TBI: substrates of dementia?

Smith, D. H., Johnson, V. E., & Stewart, W. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.29 · Cited by 699 · see citing works

Association of Mediterranean Diet with Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis

Singh, B., Parsaik, A. K., Mielke, M. M., Erwin, P. J., Knopman, D. S., Petersen, R. C., & Roberts, R. O. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-130830 · Cited by 673 · see citing works

Tau protein kinases: Involvement in Alzheimer's disease

Martin, L., Latypova, X., Wilson, C. M., Magnaudeix, A., Perrin, M.-L., Yardin, C., & Terro, F. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2012.06.003 · Cited by 631 · see citing works

Age, APOE and sex: triad of risk of Alzheimer’s disease.

Riedel, B. C., Thompson, P. M., & Brinton, R. D. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.03.012 · Cited by 627 · see citing works

Risk factors for Alzheimer’s disease

Armstrong, R. A. (2019) · Folia Neuropathologica · doi:10.5114/fn.2019.85929 · Cited by 617 · see citing works

Vascular contributions to cognitive impairment and dementia including Alzheimer's disease

Snyder, H. M., Corriveau, R. A., Craft, S., Faber, J. E., Greenberg, S. M., Knopman, D., Lamb, B. T., Montine, T. J., Nedergaard, M., Schaffer, C. B., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.10.008 · Cited by 603 · see citing works

Synergistic Effects of Traumatic Head Injury and Apolipoprotein-epsilon4 in Patients With Alzheimer's Disease

Mayeux, R., Ottman, R., Maestre, G., Ngai, C., Tang, M., Ginsberg, H., Chun, M., Tycko, B., & Shelanski, M. (1995) · Neurology · doi:10.1212/wnl.45.3.555 · Cited by 597 · see citing works

Cholinergic system during the progression of Alzheimer’s disease: therapeutic implications

Mufson, E. J., Counts, S., Perez, S. E., & Ginsberg, S. D. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.11.1703 · Cited by 589 · see citing works

Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options

Cummings, J. L., Tong, G., & Ballard, C. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad-180766 · Cited by 588 · see citing works

Implications of sleep disturbance and inflammation for Alzheimer's disease dementia

Irwin, M. R., & Vitiello, M. V. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30450-2 · Cited by 587 · see citing works

Cerebral Perfusion and the Risk of Dementia

Wolters, F. J., Zonneveld, H. I., Albert Hofman, D., van der Lugt, A., Koudstaal, P. J., Vernooij, M. W., & Ikram, M. A. (2017) · Circulation · doi:10.1161/circulationaha.117.027448 · Cited by 519 · see citing works

Serotonin in Aging, Late-Life Depression, and Alzheimer's Disease: The Emerging Role of Functional Imaging

MELTZER, C. C. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00194-2 · Cited by 517 · see citing works

You can't take it with you: Why ability assessments don't cross cultures.

Greenfield, P. M. (1997) · American Psychologist · doi:10.1037/0003-066x.52.10.1115 · Cited by 495 · see citing works

EFNS guidelines for the diagnosis and management of Alzheimer's disease

Hort, J., O’Brien, J. T., Gainotti, G., Pirttila, T., Popescu, B. O., Rektorova, I., Sorbi, S., Scheltens, P., & Dementia, O. B. O. T. E. S. P. O. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03040.x · Cited by 490 · see citing works

Smoking and increased Alzheimer's disease risk: A review of potential mechanisms

Durazzo, T. C., Mattsson, N., Weiner, M. W., & Initiative, A. D. N. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.04.009 · Cited by 461 · see citing works

Environmental risk factors for dementia: a systematic review

Killin, L. O. J., Starr, J. M., Shiue, I., & Russ, T. C. (2016) · BMC Geriatrics · doi:10.1186/s12877-016-0342-y · Cited by 442 · see citing works

Association of traumatic brain injury with subsequent neurological and psychiatric disease: A meta-analysis

Perry, D. C., Sturm, V. E., Peterson, M. J., Pieper, C. F., Bullock, T., Boeve, B. F., Miller, B. L., Guskiewicz, K. M., Berger, M. S., Kramer, J. H., et al. (2016) · Journal of Neurosurgery · doi:10.3171/2015.2.jns14503 · Cited by 440 · see citing works

Association of Traumatic Brain Injury With Late-Life Neurodegenerative Conditions and Neuropathologic Findings

Crane, P. K., Gibbons, L. E., Dams-O’Connor, K., Trittschuh, E. H., Leverenz, J. B., Keene, C. D., Sonnen, J. A., Montine, T. J., Bennett, D. A., Leurgans, S. E., et al. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.1948 · Cited by 438 · see citing works

N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer’s disease, vascular dementia and Parkinson’s disease

Olivares, D., K. Deshpande, V., Shi, Y., K. Lahiri, D., H. Greig, N., T. Rogers, J., & Huang, X. (2012) · Current Alzheimer Research · doi:10.2174/156720512801322564 · Cited by 407 · see citing works

Association of Mild Traumatic Brain Injury With and Without Loss of Consciousness With Dementia in US Military Veterans

Barnes, D. E., Byers, A. L., Gardner, R. C., Seal, K. H., Boscardin, W. J., & Yaffe, K. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.0815 · Cited by 398 · see citing works

Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms

Lanctôt, K. L., Amatniek, J., Ancoli‐Israel, S., Arnold, S. E., Ballard, C., Cohen‐Mansfield, J., Ismail, Z., Lyketsos, C., Miller, D. S., Musiek, E., et al. (2017) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2017.07.001 · Cited by 395 · see citing works

Depression in Alzheimer’s disease: overview and treatment

Lyketsos, C. G., & Olin, J. T. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01348-3 · Cited by 393 · see citing works

Traumatic Brain Injury and Alzheimer's Disease: The Cerebrovascular Link

Ramos‐Cejudo, J., Wısnıewskı, T., Marmar, C. R., Zetterberg, H., Blennow, K., de Leon, M. J., & Fossati, S. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.01.021 · Cited by 390 · see citing works

Reimagining Alzheimer's Disease—An Age-Based Hypothesis

Herrup, K. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.4521-10.2010 · Cited by 386 · see citing works

Modifiable pathways in Alzheimer’s disease: Mendelian randomisation analysis

Larsson, S. C., Traylor, M., Malik, R., Dichgans, M., Burgess, S., & Markus, H. S. (2017) · BMJ · doi:10.1136/bmj.j5375 · Cited by 382 · see citing works

What's in a name: voxel-based morphometric analyses of MRI and naming difficulty in Alzheimer's disease, frontotemporal dementia and corticobasal degeneration

Grossman, M. (2003) · Brain · doi:10.1093/brain/awh075 · Cited by 363 · see citing works

Alzheimer’s Disease In African Americans: Risk Factors And Challenges For The Future

Barnes, L. L., & Bennett, D. A. (2014) · Health Affairs · doi:10.1377/hlthaff.2013.1353 · Cited by 353 · see citing works

Microglia Function in Alzheimer’s Disease

Solito, E., & Sastre, M. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00014 · Cited by 347 · see citing works

A prospective longitudinal study of apathy in Alzheimer's disease

STARKSTEIN, S. E. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.069575 · Cited by 339 · see citing works

Truncated and modified amyloid-beta species

Kummer, M. P., & Heneka, M. T. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt258 · Cited by 338 · see citing works

Dopamine Does Double Duty in Motivating Cognitive Effort

Westbrook, A., & Braver, T. S. (2016) · Neuron · doi:10.1016/j.neuron.2015.12.029 · Cited by 313 · see citing works

Depression and Alzheimer's disease: Neurobiological links and common pharmacological targets

Caraci, F., Copani, A., Nicoletti, F., & Drago, F. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.10.022 · Cited by 312 · see citing works

Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: Implications for early intervention and therapeutics

Mao, P., & Reddy, P. H. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.08.005 · Cited by 311 · see citing works

Separate neural representations for physical pain and social rejection

Woo, C.-W., Koban, L., Kross, E., Lindquist, M. A., Banich, M. T., Ruzic, L., Andrews-Hanna, J. R., & Wager, T. D. (2014) · Nature Communications · doi:10.1038/ncomms6380 · Cited by 310 · see citing works

Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer’s disease: a systematic review

Jeremic, D., Jiménez-Díaz, L., & Navarro-López, J. D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101496 · Cited by 306 · see citing works

Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer’s disease

Bennett, R. E., Robbins, A. B., Hu, M., Cao, X., Betensky, R. A., Clark, T., Das, S., & Hyman, B. T. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1710329115 · Cited by 299 · see citing works

Executive Functions in Alzheimer Disease: A Systematic Review

Guarino, A., Favieri, F., Boncompagni, I., Agostini, F., Cantone, M., & Casagrande, M. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00437 · Cited by 280 · see citing works

Orbitofrontal and anterior cingulate cortex neurofibrillary tangle burden is associated with agitation in Alzheimer disease

Tekin, S., Mega, M. S., Masterman, D. M., Chow, T. W., Garakian, J., Vinters, H. V., & Cummings, J. L. (2001) · Annals of Neurology · doi:10.1002/ana.72 · Cited by 278 · see citing works

“Is dopamine involved in Alzheimer's disease?”

Martorana, A., & Koch, G. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00252 · Cited by 276 · see citing works

Alzheimer’s disease after remote head injury: an incidence study

Schofield, P. W., Tang, M., Marder, K., Bell, K., Dooneief, G., Chun, M., Sano, M., Stern, Y., & Mayeux, R. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.62.2.119 · Cited by 260 · see citing works

Sex, Apolipoprotein E ε4 Status, and Hippocampal Volume in Mild Cognitive Impairment

Fleisher, A. (2005) · Archives of Neurology · doi:10.1001/archneur.62.6.953 · Cited by 256 · see citing works

NMDA receptor function, memory, and brain aging

Newcomer, J. W., Farber, N. B., & Olney, J. W. (2000) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2000.2.3/jnewcomer · Cited by 220 · see citing works

Pulse wave velocity is associated with β-amyloid deposition in the brains of very elderly adults

Hughes, T. M., Kuller, L. H., Barinas-Mitchell, E. J. M., Mackey, R. H., McDade, E. M., Klunk, W. E., Aizenstein, H. J., Cohen, A. D., Snitz, B. E., Mathis, C. A., et al. (2013) · Neurology · doi:10.1212/01.wnl.0000435301.64776.37 · Cited by 190 · see citing works

Structural correlates of apathy in Alzheimer's disease

Apostolova, L. G., Akopyan, G. G., Partiali, N., Steiner, C. A., Dutton, R. A., Hayashi, K. M., Dinov, I. D., Toga, A. W., Cummings, J. L., & Thompson, P. M. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000103914 · Cited by 190 · see citing works

Arterial Stiffness and β-Amyloid Progression in Nondemented Elderly Adults

Hughes, T. M., Kuller, L. H., Barinas‐Mitchell, E., McDade, E., Klunk, W. E., Cohen, A. D., Mathis, C. A., DeKosky, S. T., Price, J. C., & López, O. L. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.186 · Cited by 189 · see citing works

Reimagining cholinergic therapy for Alzheimer’s disease

Giacobini, E., Cuello, A. C., & Fisher, A. (2022) · Brain · doi:10.1093/brain/awac096 · Cited by 187 · see citing works

Epigenetics of Alzheimer’s Disease

Perković, M. N., Paska, A. V., Konjevod, M., Kouter, K., Štrac, D. Š., Erjavec, G. N., & Pivac, N. (2021) · Biomolecules · doi:10.3390/biom11020195 · Cited by 181 · see citing works

Risk for late-life re-injury, dementia and death among individuals with traumatic brain injury: a population-based study

Dams-O’Connor, K., Gibbons, L. E., Bowen, J. D., McCurry, S. M., Larson, E. B., & Crane, P. K. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303938 · Cited by 178 · see citing works

Cognitive and neuropathologic correlates of Stroop Color-Word Test performance in Alzheimer's disease.

Bondi, M. W., Serody, A. B., Chan, A. S.-Y., Eberson, S., Delis, D. C., Hansen, L. A., & Salmon, D. P. (2002) · Neuropsychology · doi:10.1037/0894-4105.16.3.335 · Cited by 177 · see citing works

The Role of the Tripartite Glutamatergic Synapse in the Pathophysiology of Alzheimer’s Disease

Rudy, C. C., Hunsberger, H. C., Weitzner, D. S., & Reed, M. N. (2015) · Aging and Disease · doi:10.14336/ad.2014.0423 · Cited by 168 · see citing works

Bilingualism: Pathway to Cognitive Reserve

Bialystok, E. (2021) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2021.02.003 · Cited by 167 · see citing works

APOE and cholesterol homeostasis in Alzheimer's disease

Leduc, V., Jasmin, S. B., & Poirier, J. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.07.008 · Cited by 158 · see citing works

Apathy and anxiety are early markers of Alzheimer's disease.

Johansson, M., Stomrud, E., Lindberg, O., Westman, E., Johansson, P., van Westen, D., Mattsson, N., & Hansson, O. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.10.008 · Cited by 156 · see citing works

Recent advances in the neurobiology and neuropharmacology of Alzheimer’s disease

Kumar, K., Kumar, A., Keegan, R. M., & Deshmukh, R. R. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.12.053 · Cited by 153 · see citing works

Neuropathologic Correlates of Apathy in Alzheimer’s Disease

Marshall, G. A., Fairbanks, L. A., Tekin, S., Vinters, H. V., & Cummings, J. L. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000090674 · Cited by 147 · see citing works

Disparities in cognitive functioning by race/ethnicity in the Baltimore Memory Study.

Schwartz, B. S., Glass, T. A., Bolla, K. I., Stewart, W. F., Glass, G. E., Rasmussen, M., Bressler, J. P., Shi, W., & Bandeen‐Roche, K. (2003) · Environmental Health Perspectives · doi:10.1289/ehp.6727 · Cited by 144 · see citing works

Brain excitability and connectivity of neuronal assemblies in Alzheimer's disease: From animal models to human findings

D’Amelio, M., & Rossini, P. M. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.07.001 · Cited by 144 · see citing works

A unifying hypothesis for Alzheimer's disease: from plaques to neurodegeneration

Edwards, F. A. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2019.03.003 · Cited by 140 · see citing works

Culture, Ethnicity, and Level of Education in Alzheimer's Disease

Rosselli, M., Vélez-Uribe, I., Ahne, E., & Shihadeh, L. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01193-z · Cited by 140 · see citing works

Pulse Pressure in Relation to Tau-Mediated Neurodegeneration, Cerebral Amyloidosis, and Progression to Dementia in Very Old Adults

Nation, D. A., Edmonds, E. C., Bangen, K. J., Delano‐Wood, L., Scanlon, B. K., Han, S. D., Edland, S. D., Salmon, D. P., Galasko, D. R., & Bondi, M. W. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2014.4477 · Cited by 134 · see citing works

Disorders of the visual system in Alzheimer's disease.

Mendez, M. F., Tomsak, R. L., & Remler, B. F. (1990) · PubMed · Cited by 129 · see citing works

Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis

Farrer, L. A. (1997) · JAMA · doi:10.1001/jama.1997.03550160069041 · Cited by 124 · see citing works

Alzheimer’s Disease in the Latino Community: Intersection of Genetics and Social Determinants of Health

Vega, I. E., Cabrera, L., Wygant, C., Velez-Ortiz, D., & Counts, S. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-161261 · Cited by 115 · see citing works

Education differentially contributes to cognitive reserve across racial/ethnic groups

Avila, J. F., Rentería, M. A., Jones, R. N., Vonk, J. M. J., Turney, I. C., Sol, K., Šeblová, D., Arias, F., Hill‐Jarrett, T. G., Levy, S.-A. T., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12176 · Cited by 115 · see citing works

Theories of Aging and the Prevalence of Alzheimer’s Disease

Trevisan, K., Cristina-Pereira, R., Silva-Amaral, D., & Aversi‐Ferreira, T. A. (2019) · BioMed Research International · doi:10.1155/2019/9171424 · Cited by 111 · see citing works

Vascular Risk and β ‐Amyloid Are Synergistically Associated with Cortical Tau

Rabin, J. S., Yang, H., Schultz, A. P., Hanseeuw, B. J., Hedden, T., Viswanathan, A., Gatchel, J. R., Marshall, G. A., Kilpatrick, E. P., Klein, H., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25399 · Cited by 109 · see citing works

Neuroanatomical spread of amyloid β and tau in Alzheimer’s disease: implications for primary prevention

Insel, P. S., Mormino, E. C., Aisen, P. S. S., Thompson, W. K., & Donohue, M. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa007 · Cited by 109 · see citing works

Stress as risk factor for Alzheimer’s disease

Caruso, A., Nicoletti, F., Mango, D., Saidi, A., Orlando, R., & Scaccianoce, S. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.04.017 · Cited by 99 · see citing works

Serotonin 5-HT6 receptors affect cognition in a mouse model of Alzheimer’s disease by regulating cilia function

Hu, L., Wang, B., & Zhang, Y. (2017) · Alzheimer's Research & Therapy · doi:10.1186/s13195-017-0304-4 · Cited by 98 · see citing works

The neural correlates of naming and fluency deficits in Alzheimer's disease: an FDG‐PET study

Melrose, R. J., Campa, O., Harwood, D. G., Osato, S. S., Mandelkern, M. A., & Sultzer, D. L. (2009) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2229 · Cited by 95 · see citing works

Traumatic brain injury and risk of dementia and Alzheimer's disease: a systematic review and meta-analysis

Gu, D., Ou, S., & Liu, G. (2022) · Neuroepidemiology · doi:10.1159/000520966 · Cited by 94 · see citing works

REVIEW: Apathy Diagnosis, Assessment, and Treatment in Alzheimer's Disease

Robert, P. H., Mulin, E., Malléa, P., & David, R. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2009.00132.x · Cited by 84 · see citing works

Self-reported head injury and risk of late-life impairment and AD pathology in an AD center cohort

Abner, E. L., Nelson, P. T., Schmitt, F. A., Browning, S. R., Fardo, D. W., Wan, L., Jicha, G. A., Cooper, G. E., Smith, C. D., Caban-Holt, A. M., et al. (2014) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000355478 · Cited by 84 · see citing works

Bilateral Symmetry of Morphologic Lesions in Alzheimer's Disease

Moossy, J. J., Zubenko, G. S., Martinez, A. J., & Rao, G. R. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520270025015 · Cited by 80 · see citing works

3D mapping of language networks in clinical and pre-clinical Alzheimer’s disease

Apostolova, L. G., Lu, P. H., Rogers, S., Dutton, R. A., Hayashi, K. M., Toga, A. W., Cummings, J. L., & Thompson, P. M. (2007) · Brain and Language · doi:10.1016/j.bandl.2007.03.008 · Cited by 79 · see citing works

Psychosis of Alzheimer's disease: clinical characteristics and history

Schneider, L. S., & Dagerman, K. (2003) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(03)00092-x · Cited by 72 · see citing works

Reduced striatal dopamine receptors in Alzheimer's disease

Pizzolato, G., Chierichetti, F., Fabbri, M., Cagnin, A., Dam, M., Ferlin, G., & Battistin, L. (1996) · Neurology · doi:10.1212/wnl.47.4.1065 · Cited by 72 · see citing works

Is traumatic brain injury a risk factor for neurodegeneration? A meta-analysis of population-based studies

Huang, C.-H., Lin, C.-W., Lee, Y., Huang, C., Huang, R.-Y., Tai, Y., Wang, K., Yang, S., Sun, Y., & Wang, H. (2018) · BMC Neurology · doi:10.1186/s12883-018-1187-0 · Cited by 67 · see citing works

A Primer on the Evolution of Aducanumab: The First Antibody Approved for Treatment of Alzheimer’s Disease

Mukhopadhyay, S., & Banerjee, D. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215065 · Cited by 66 · see citing works

Neuropsychology of Alzheimer's Disease

Peña‐Casanova, J., Sánchez‐Benavides, G., de Sola, S., Manero-Borràs, R. M., & Casals-Coll, M. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.08.015 · Cited by 65 · see citing works

Psychosis in Alzheimer's disease is associated with frontal metabolic impairment and accelerated decline in working memory: findings from the Alzheimer's Disease Neuroimaging Initiative

Koppel, J., Sunday, S., Goldberg, T. E., Davies, P., Christen, E., & Greenwald, B. S. (2014) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2012.10.028 · Cited by 65 · see citing works

Stress, exercise, and Alzheimer’s disease: A neurovascular pathway

Nation, D. A., Hong, S., Jak, A. J., Delano‐Wood, L., Mills, P. J., Bondi, M. W., & Dimsdale, J. E. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.02.034 · Cited by 62 · see citing works

Racial Differences in the Progression of Cognitive Decline in Alzheimer Disease

Barnes, L. L., Wilson, R. S., Li, Y., Aggarwal, N. T., Gilley, D. W., McCann, J. J., & Evans, D. A. (2005) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200511000-00006 · Cited by 60 · see citing works

The relationship between quantitative measures of dementia and of degenerative changes in the cerebral grey matter of elderly subjects.

Roth, M., Tomlinson, B. E., & Blessed, G. (1967) · PubMed · Cited by 59 · see citing works

Glucose metabolism: A link between traumatic brain injury and Alzheimer’s disease

Xu, X., Yang, M.-S., Zhang, B., Niu, F., Dong, J., & Liu, B. (2020) · Chinese Journal of Traumatology · doi:10.1016/j.cjtee.2020.10.001 · Cited by 59 · see citing works

Association between cerebral metabolism and Rey–Osterrieth Complex Figure Test performance in Alzheimer's disease

Melrose, R. J., Harwood, D. G., Khoo, T., Mandelkern, M. A., & Sultzer, D. L. (2013) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2012.763113 · Cited by 58 · see citing works

Alzheimer’s dementia: pathogenesis and impact of cardiovascular risk factors on cognitive decline

Wanleenuwat, P., Iwanowski, P. S., & Kozubski, W. P. (2019) · Postgraduate Medicine · doi:10.1080/00325481.2019.1657776 · Cited by 57 · see citing works

Central Serotonergic Activity is Related to the Aggressive Behaviors of Alzheimer's Disease

Lanctôt, K. L. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00339-1 · Cited by 55 · see citing works

Visual Features in Alzheimer’s Disease: From Basic Mechanisms to Clinical Overview

Cerquera-Jaramillo, M. A., Nava-Mesa, M. O., González-Reyes, R. E., Téllez-Conti, C., & de‐la‐Torre, A. (2018) · Neural Plasticity · doi:10.1155/2018/2941783 · Cited by 54 · see citing works

Head or brain injuries and Alzheimer's disease: a nested case-control register study

Tolppanen, A., Taipale, H., & Hartikainen, S. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.04.010 · Cited by 53 · see citing works

Extent, pattern, and correlates of remote memory impairment in Alzheimer's disease and Parkinson's disease.

Fama, R., Sullivan, E. V., Shear, P. K., Stein, M., Yesavage, J. A., Tinklenberg, J. R., & Pfefferbaum, A. (2000) · Neuropsychology · doi:10.1037//0894-4105.14.2.265 · Cited by 50 · see citing works

Perspective on race and ethnicity in Alzheimer's disease research

Weiner, M. (2007) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2007.10.016 · Cited by 48 · see citing works

Cholinergic receptor binding in unimpaired older adults, mild cognitive impairment, and Alzheimer’s disease dementia

Sultzer, D. L., Lim, A. C., Gordon, H. L., Yarns, B. C., & Melrose, R. J. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00954-w · Cited by 48 · see citing works

Acculturation in Context: The Relationship Between Acculturation and Socioenvironmental Factors With Level of and Change in Cognition in Older Latinos

Lamar, M., Barnes, L. L., Leurgans, S. E., Fleischman, D. A., Farfel, J. M., Bennett, D. A., & Márquez, D. X. (2020) · The Journals of Gerontology Series B · doi:10.1093/geronb/gbaa156 · Cited by 44 · see citing works

Extent, pattern, and correlates of remote memory impairment in Alzheimer's disease and Parkinson's disease.

Fama, R., Sullivan, E. V., Shear, P. K., et al. (2000) · Neuropsychology · doi:10.1037/0894-4105.14.2.265 · Cited by 41 · see citing works

Risk of incident clinical diagnosis of Alzheimer's disease–type dementia attributable to pathology‐confirmed vascular disease

Dodge, H. H., Zhu, J. Y., Woltjer, R. L., Nelson, P. T., Bennett, D. A., Cairns, N. J., Fardo, D. W., Kaye, J. A., Erten‐Lyons, D., Mattek, N., et al. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.11.003 · Cited by 40 · see citing works

Stress-Induced Neurodegeneration: The Potential for Coping as Neuroprotective Therapy

Kline, S. A., & Mega, M. S. (2020) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317520960873 · Cited by 38 · see citing works

Secular Trends in Cognitive Performance in Older Black and White U.S. Adults, 1993–2012: Findings From the Chicago Health and Aging Project

Weuve, J., Rajan, K. B., Barnes, L. L., Wilson, R. S., & Evans, D. A. (2017) · The Journals of Gerontology Series B · doi:10.1093/geronb/gbx167 · Cited by 37 · see citing works

5-HT7 receptor stimulation and blockade: a therapeutic paradox about memory formation and amnesia

Meneses, A. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00207 · Cited by 35 · see citing works

Cholinergic Receptor Binding in Alzheimer Disease and Healthy Aging: Assessment In Vivo with Positron Emission Tomography Imaging

Sultzer, D. L., Melrose, R. J., Riskin-Jones, H. H., Narvaez, T. A., Veliz, J., Ando, T. K., Juarez, K. O., Harwood, D. G., Brody, A. L., & Mandelkern, M. A. (2017) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2016.11.011 · Cited by 35 · see citing works

5-HT7 receptors in Alzheimer's disease.

Solas, M., Dam, D. V., Janssens, J., Ocáriz, U., Vermeiren, Y., de Deyn, P., & Ramírez, M. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105185 · Cited by 34 · see citing works

Effects of educational attainment on the clinical expression of Alzheimer's disease: Results from a research registry

Fritsch, T., McClendon, M. J., Smyth, K. A., Lerner, A. J., Chen, C. H., Petot, G. J., Debanne, S. M., Soas, A., & Friedland, R. P. (2001) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750101600606 · Cited by 32 · see citing works

Metabolic correlates of executive dysfunction

Bracco, L., Bessi, V., Piccini, C., Mosconi, L., Pupi, A., & Sorbi, S. (2007) · Journal of Neurology · doi:10.1007/s00415-006-0488-1 · Cited by 31 · see citing works

Cortical signatures of cognition and their relationship to Alzheimer’s disease

Initiative, A. D. N., Gross, A. L., Manly, J. J., Pa, J., Johnson, J. K., Park, L. Q., Mitchell, M. B., Melrose, R. J., Inouye, S. K., & McLaren, D. G. (2012) · Brain Imaging and Behavior · doi:10.1007/s11682-012-9180-5 · Cited by 26 · see citing works

Associations of Race-Ethnicity and History of Traumatic Brain Injury With Age at Onset of Alzheimer’s Disease

Bailey, K. C., Burmaster, S. A., Schaffert, J., LoBue, C., Vela, D., Rossetti, H. C., & Cullum, C. M. (2019) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.19010002 · Cited by 14 · see citing works

Amyloid-PET imaging offers small improvements in predictions of future cognitive trajectories

Ackley, S., Hayes-Larson, E., Brenowitz, W. D., Swinnerton, K. N., Mungas, D., Fletcher, E., Singh, B., Whitmer, R., Decarli, C., & Glymour, M. (2021) · NeuroImage: Clinical · doi:10.1016/j.nicl.2021.102713 · Cited by 8 · see citing works

Understanding neuropsychiatric symptoms in Alzheimer’s disease: challenges and advances in diagnosis and treatment

Pless, A., Ware, D., Saggu, S., Rehman, H., Morgan, J. C., & Wang, Q. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1263771 · Cited by 122 · see citing works

Alzheimer’s Disease—Biochemical and Psychological Background for Diagnosis and Treatment

Beata, B.-K., Jelski, W., Kornhuber, J., Lewczuk, P., & Mroczko, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021059 · Cited by 105 · see citing works

Alzheimer's disease pathophysiology in the Retina

Gaire, B. P., Koronyo, Y., Fuchs, D.-T. S., Shi, H., Rentsendorj, A., Danziger, R., Vit, J., Mirzaei, N., Doustar, J., Sheyn, J., et al. (2024) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2024.101273 · Cited by 102 · see citing works

Unlocking the Therapeutic Potential of Medicinal Plants for Alzheimer’s Disease: Preclinical to Clinical Trial Insights

Nagori, K., Nakhate, K. T., Yadav, K., Ajazuddin, & Pradhan, M. (2023) · Future Pharmacology · doi:10.3390/futurepharmacol3040053 · Cited by 61 · see citing works

Akt signaling pathway: a potential therapy for Alzheimer’s disease through glycogen synthase kinase 3 beta inhibition

Limantoro, J., de Liyis, B. G., & Sutedja, J. C. (2023) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-023-00751-2 · Cited by 59 · see citing works

Altered ubiquitin signaling induces Alzheimer’s disease-like hallmarks in a three-dimensional human neural cell culture model

Maniv, I., Sarji, M., Bdarneh, A., Feldman, A., Ankawa, R., Koren, E., Magid-Gold, I., Reis, N., Soteriou, D., Salomon‐Zimri, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41545-7 · Cited by 52 · see citing works

From Inhalation to Neurodegeneration: Air Pollution as a Modifiable Risk Factor for Alzheimer’s Disease

Olloquequi, J., Díaz‐Peña, R., Verdaguer, E., Ettcheto, M., Auladell, C., & Camins, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136928 · Cited by 35 · see citing works

Retinal ganglion cell vulnerability to pathogenic tau in Alzheimer’s disease

Davis, M. R., Robinson, E., Koronyo, Y., Salobrar‐García, E., Rentsendorj, A., Gaire, B. P., Mirzaei, N., Kayed, R., Sadun, A. A., Ljubimov, A. V., et al. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-01935-y · Cited by 33 · see citing works

Development of Activity Rules and Chemical Fragment Design for In Silico Discovery of AChE and BACE1 Dual Inhibitors against Alzheimer’s Disease

Quang-Bao, L., Baecker, D., Dung, D. T. M., Nhung, N. P., Thuần, N. T. D., Nguyen, P. L., Dung, P. T. P., Hương, T. T. L., Rasulev, B., Casañola‐Martín, G. M., et al. (2023) · Molecules · doi:10.3390/molecules28083588 · Cited by 22 · see citing works

Extracellular vesicles from hiPSC-derived NSCs protect human neurons against Aβ-42 oligomers induced neurodegeneration, mitochondrial dysfunction and tau phosphorylation

Rao, S., Madhu, L. N., Babu, R. S., Shankar, G., Kotian, S., Nagarajan, A., Upadhya, R., Narvekar, E., Cai, J. J., & Shetty, A. K. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04324-3 · Cited by 18 · see citing works

Targeting Amyloid Beta Aggregation and Neuroinflammation in Alzheimer’s Disease: Advances and Future Directions

Dagla, I., Gkikas, F., Gikas, E. E., & Tsarbopoulos, A. (2026) · Cells · doi:10.3390/cells15030295 · Cited by 15 · see citing works

Innovative strategies for overcoming blood-brain barrier challenges in Alzheimer’s disease: A focus on green-synthesized metallic nanoparticles

Nagori, K., Nakhate, K. T., Yadav, D. K., Thakur, A., Ajazuddin, M., & Pradhan, M. (2024) · Inorganic Chemistry Communications · doi:10.1016/j.inoche.2024.113604 · Cited by 14 · see citing works

Functional Implications of Protein Arginine Methyltransferases (PRMTs) in Neurodegenerative Diseases

Angelopoulou, E., Pyrgelis, E.-S., Ahire, C. G., Suman, P., Mishra, A., & Piperi, C. (2023) · Biology · doi:10.3390/biology12091257 · Cited by 14 · see citing works

Tailoring the biomarkers of Alzheimer’s disease using a gut microbiome-centric approach: Preclinical, clinical, and regulatory perspectives

Sharma, S., Bashir, B., Kolekar, K. A., Acharya, A., Gupta, M., Jena, R., Vishwas, S., Kaur, J., Gupta, G., Kumbhar, P., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102888 · Cited by 12 · see citing works

Unlocking the Vitamin Puzzle: Investigating Levels in People With Alzheimer's Disease Versus Healthy Controls Through Systematic Review and Network Meta‐Analysis

Marwaha, S., Agarwal, R., Tripathi, M., & Tripathi, S. (2025) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.70007 · Cited by 11 · see citing works

Quantifying neurovascular coupling through a concurrent assessment of arterial, capillary, and neuronal activation in humans: A multimodal EEG-fNIRS-TCD investigation

Burma, J. S., Oni, I. K., Lapointe, A. P., Rattana, S., Schneider, K., Debert, C. T., Smirl, J. D., & Dunn, J. F. (2024) · NeuroImage · doi:10.1016/j.neuroimage.2024.120910 · Cited by 10 · see citing works

Future Perspectives of NMDAR in CNS Disorders

Capó, T., Rebassa, J. B., Raïch, I., Lillo, J., Badia, P., Navarro, G., & Reyes‐Resina, I. (2025) · Molecules · doi:10.3390/molecules30040877 · Cited by 10 · see citing works

Beyond expectations: investigating nilotinib’s potential in attenuating neurodegeneration in Alzheimer’s disease

Tocci, D. R., Fogel, M., Gupta, V., Kim, P. S.-H., Latimer, J. J., Adlimoghaddam, A., Robison, L. S., & Albensi, B. C. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01706-w · Cited by 11 · see citing works

Oroxylum indicum (L.) Leaf Extract Attenuates β-Amyloid-Induced Neurotoxicity in SH-SY5Y Cells

Palachai, N., Buranrat, B., Noisa, P., & Mairuae, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26072917 · Cited by 10 · see citing works

MGST3 regulates BACE1 protein translation and amyloidogenesis by controlling the RGS4-mediated AKT signaling pathway

Pu, Y., Yang, J., Pan, Q., Li, C., Wang, L., Xie, X., Chen, X., Xiao, F., & Chen, G. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107530 · Cited by 9 · see citing works

In vitro and in vivo Investigations of 4-Substituted 2-Phenylquinazoline derivatives as multipotent ligands for the treatment of Alzheimer’s disease

Kumar, V., Jangid, K., Kumar, V., Kumar, V., Mishra, J., Arora, T., Dwivedi, A. R., Kumar, P., Bhatti, J. S., Parkash, J., et al. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108126 · Cited by 9 · see citing works

RNAi therapeutics for diseases involving protein aggregation: fazirsiran for alpha-1 antitrypsin deficiency-associated liver disease

Strnad, P., & Martín, J. S. (2023) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2023.2239707 · Cited by 9 · see citing works

CAR Treg therapies for neurodegenerative diseases

Stein, D. N., & Gendelman, H. E. (2026) · iScience · doi:10.1016/j.isci.2026.114988 · Cited by 8 · see citing works

Advanced glycation end products: understanding their health risks and effective prevention strategies

Erim, B., & Binici, H. İ. (2024) · Nutrire · doi:10.1186/s41110-024-00298-z · Cited by 8 · see citing works

Amyloid deposition and its association with depressive symptoms and cognitive functions in late-life depression: a longitudinal study using amyloid-β PET images and neuropsychological measurements

Kim, K., Jang, Y. J., Shin, J., Park, M. J., Kim, H., Seong, J., & Jeon, H. J. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01562-0 · Cited by 8 · see citing works

Histone Deacetylase 2 in Alzheimer’s Disease: A Comprehensive Molecular Blueprint for Therapeutic Targeting

Asadi, K., Radha, K., Satarker, S., & Gurram, P. C. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05264-y · Cited by 6 · see citing works

Potential Application of MicroRNAs and Some Other Molecular Biomarkers in Alzheimer’s Disease

Paprzycka, O., Wieczorek, J., Nowak, I., Madej, M., & Strzałka‐Mrozik, B. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46060304 · Cited by 6 · see citing works

Saponins: A class of bioactive natural products with wide applications in human health

da Silva, R. M. G., Kacew, S., & Granero, F. O. (2024) · Studies in natural products chemistry · doi:10.1016/b978-0-443-15756-1.00013-6 · Cited by 5 · see citing works

Unveiling the Protective Roles of Melatonin on Glial Cells in the Battle Against Alzheimer’s Disease—Insights from In Vivo and In Vitro Studies

Sirimaharaj, N., Thiankhaw, K., Chattipakorn, N., & Chattipakorn, S. C. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04904-7 · Cited by 5 · see citing works

Mapping trends and hotspots of mitochondrial dysfunction in Alzheimer’s disease from 2013 to 2022: a bibliometric analysis of global research

Wang, G., Hassan, L. A., Chu, Y.-H., Yang, X.-P., Wang, S.-X., Zhu, H.-X., & Li, Y. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1199625 · Cited by 5 · see citing works

Rlip76 in ageing and Alzheimer’s disease: Focus on oxidative stress and mitochondrial mechanisms

Bandaru, M., Sultana, O. F., Islam, M. A., Alvir, R. V., & Reddy, P. H. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102600 · Cited by 4 · see citing works

Can cognitive reserve offset APOE-related Alzheimer’s risk? A systematic review

da Silva, S. P., Lampraki, C., Rêgo, T. S., Ghisletta, P., Kliegel, M., Maurer, J., Studer, M., Gouveia, É. R., Nascimento, M. D. M., & Ihle, A. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102809 · Cited by 4 · see citing works

Antiglycative Properties of Anti-Dementia Drugs—In Vitro, In Silico Studies and a Systematic Literature Review

Orlof, W., Ładny, J. R., Michalak, D., Żendzian‐Piotrowska, M., Zalewska, A., & Maciejczyk, M. (2025) · Antioxidants · doi:10.3390/antiox14121509 · Cited by 3 · see citing works

Brain Primer, Part 2: Pathophysiology of Neurodegeneration

Johnson, S. L. (2026) · Journal of Nuclear Medicine Technology · doi:10.2967/jnmt.125.271788 · Cited by 3 · see citing works

Pathophysiology of Alzheimer’s disease: an insight into the genetic factors, hypotheses, redox imbalance, and antioxidant intervention

Abdulkadir, T. S., & Ayo, J. O. (2024) · Comparative Clinical Pathology · doi:10.1007/s00580-024-03603-4 · Cited by 3 · see citing works

Revolutionizing Therapeutic Approaches Against Pathophysiology of Alzheimer’s Disease: A Therapeutic Review

Saini, M., Rohilla, S., & Kumar, R. (2025) · Current Aging Science · doi:10.2174/0118746098376646250715094707 · Cited by 3 · see citing works

Mini-review: Processed red meat intake and risk of neurodegenerative diseases

Chen, K.-Q., Cao, W.-J., Liu, Z., & Liu, R.-Z. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1663647 · Cited by 3 · see citing works

Inhibition of the Transforming Growth Factor‐β Signaling Pathway Confers Neuroprotective Effects on Beta‐Amyloid‐Induced Direct Neurotoxicity and Microglia‐Mediated Neuroinflammation

Tiong, S. Q., Mohgan, R., Quek, J. Y., Liew, J. Y. S., Wong, G. Y. S., Thang, Z. Q., Chan, Z. L., Gan, S. Y., & Chan, E. W. L. (2025) · Neurology Research International · doi:10.1155/nri/8948290 · Cited by 3 · see citing works

The Retinal Dopaminergic Circuit as a Biomarker for Huntington’s and Alzheimer’s Diseases

Blanco-Hernán, P., Aguado, L., Asensio, M. J., Gómez, A., de la Villa, P., Casarejos, M. J., & Mansilla, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125532 · Cited by 2 · see citing works

Serum Levels of Plasminogen Activator Inhibitor-1 in Patients with Parkinson’s Disease

Tanrikulu, A. M., Özdilek, B., & Ağırbaşlı, M. A. (2024) · Medical Principles and Practice · doi:10.1159/000540854 · Cited by 2 · see citing works

Dementia from Small Vessel Disease Versus Alzheimer’s Disease: Separate Diseases or Distinct Manifestations of Cerebral Capillopathy Due to Blood–Brain Barrier Dysfunction? A Pilot Study

Joseph, C. R., Melin, D., Wanner, L. K., Hartman, B., Badelita, J., Conser, L., Kline, H. D., Pradhan, P., & Love, K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115040 · Cited by 2 · see citing works

Bio-AD: A Transfer Learning Approach for Diagnosis of Alzheimer’s Diseases in MRI ScansPreprint

Fareed, M. M. S., Ahmed, G., Zikria, S., & Jamal, S. A. (2024) · Preprints.org · doi:10.20944/preprints202408.2010.v1 · Cited by 2 · see citing works

Exploring the Potential of Herbal Compounds as Autophagy Modulators in Alzheimer's Disease: A Comprehensive Review

Yadav, E., Mandal, A. K., Sah, A. K., Poudel, S., Pathak, P., Khalilullah, H., Jaremko, M., Emwas, A.-H. M., Yadav, P. S., & Verma, A. (2024) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273298025240905130205 · Cited by 1 · see citing works

MTHFR Polymorphisms and Plasma Homocysteine in Early-Onset Alzheimer's Disease: A Case-Control Study

Hamad, N. A., Eltayeb, L. B., & Yassin, H. M. (2024) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/2996 · Cited by 1 · see citing works

Long-Term Treatment with Fluoroethylnormemantine (FENM) Alleviated Memory Deficits, Amyloid Pathology, and Microglial Reaction in APP/PS1 Mice

Freyssin, A., Carles, A., Moha, B., Rubinstenn, G., & Maurice, T. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00522 · Cited by 1 · see citing works

Potential Causal Association Between Follicle‐Stimulating Hormone and Alzheimer's Disease: Genetic Loci Study and Mendelian Randomization Study

Ding, C., Xu, X., Xu, B., & Wu, J. (2025) · Annals of Human Genetics · doi:10.1111/ahg.70004 · Cited by 1 · see citing works

Pathological Insights into Neurodegenerative and Neurodevelopmental Disorders: Perspectives for the Development of Novel Treatment Approaches

Agarwal, U., Paliwal, S., Yadav, V., Pannu, A. S., Tonk, R. K., & Verma, S. K. (2025) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273402657250905055635 · Cited by 1 · see citing works

Network Pharmacology and Computational Insights into PTGS2 Interactions with Apigenin and Genistein for Alzheimer's Disease Therapeutics

Loganathan, T., Shaistha Shabnam, S., Devi, M. S. S., & Doss, C. G. P. (2025) · ChemistrySelect · doi:10.1002/slct.202501684 · Cited by 1 · see citing works

LAX1 as a core biomarker in Alzheimer’s disease and periodontitis via the STAT signaling pathway

Guo, H., Guo, T., Wang, X., Bao, Y., Zhang, Z., Xue, F., & Cheng, D. (2025) · BMC Geriatrics · doi:10.1186/s12877-025-06865-x · Cited by 1 · see citing works

Potential Therapeutic Strategy for Neurodegenerative Disorders: Insights from Natural Cannabis Compounds and Analogues

Tian, L., Zhang, B., Yang, X., Zhai, X., Gao, Y., Zhang, Y., Xie, X., Zhang, D., & Liang, C. (2025) · Springer eBooks · doi:10.1007/978-3-031-95878-6_11 · Cited by 1 · see citing works

Surface-Engineered Smart Carbon Quantum Dots at the Brain Interface for Neurotherapeutics and Brain Imaging: From Surface to Synapse

Podder, A., Kosara, S., Yadav, S. K., Verma, D., Mishra, D. T. P., Solanki, R., Bhatia, D. D., & Yadav, A. K. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.5c08199 · Cited by 1 · see citing works

Evaluating the molecular drivers of physical inactivity and muscle atrophy as initiating factors in cognitive impairment

Kerr, N. R. (2023) · doi:10.32469/10355/97056

Strategies for Treating Alzheimer’s: Current Approaches and Future Perspectives

Skuba, A., Załuska, K., Świdniak, A., Biskup, M., Bartoszek, A., Kopeć, K., Marut, A., Misiuk, J., Adamiuk, J., & Nykiel, S. (2025) · Quality in Sport · doi:10.12775/qs.2025.41.58829

Retinal proteomics in neurodegeneration: Insights into ocular and brain disorders

Mirshahvaladi, S., Gaire, B., Kashani, S., Guha, A., Koronyo, Y., Fuchs, D., You, Y.-Y., Black, K. L., Paulo, J. A., Graham, S. L., et al. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00291

Therapeutic Potential of Medicinal Mushrooms on Alzheimer’s Disease

Albahttiti, A. T. I., Akubardia, N., Tasnim, D., & Hamzeh, L. (2025) · Nutritional neurosciences · doi:10.1007/978-981-95-2774-8_8

Therapeutics immunotargets for Tauopathy

Chinnathambi, S., & Rangappa, N. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2025.10.015

Synergistic retinal UCHL1 dysregulation and synaptic vulnerability reflect Alzheimer’s disease severityPreprint

Rentsendorj, A., Vit, J., Hutton, A., Koronyo, Y., Shahin, S., Robinson, E., Barrón, E., Rodriguez, A., Gaire, B. P., Jallow, O., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.03.703406

Comorbidities and their Impact on Disease Progression: Focused on Alzheimer's Disease

Sonawane, G., Pansare, K. V., Sonawane, D. D., Patil, C. D., & Mahajan, S. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898814953126010012

Neuroprotective Effects of Ginkgo biloba Extract in Neurological Disorders: Integrating Anti-Inflammatory and Antioxidant Mechanisms

Bhat, K. M. R., Prasanna, L. C., Thonse, N. K., Potu, B. K., & Kateel, R. (2026) · Complementary Medicine Research · doi:10.1159/000552633

Integrative transcriptomic analysis identifies meningeal-hippocampal immune communication in Alzheimer’s disease

Yan, C., Chen, Z., Yan, Y., Wang, M., Chen, W., Zhou, F., & Liu, Q. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08414-5

Small Molecules as Anti-Alzheimer’s Scaffolds

Hazra, R., Roy, S., Gayen, S., Parui, A., Arshad, A., Roy, N., & Sarkar, A. N. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898815646126010013

Repressor Element 1 Silencing Transcription Factor as a central regulator of autophagy and neuroinflammation in Alzheimer's disease

Dilip, P. I., Daksh, R., Sharma, P., Khanna, S., Bojja, S. L., Singh, A. K., & Nampoothiri, M. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179168

Hematological Considerations in Immunotherapy for Alzheimer's Disease

Kumar, R. R., Pandey, R., Antal, S., Rani, S., & Alam, M. S. (2026) · doi:10.1002/9781394336241.ch8

Sigma-1 Receptor Ligand Blarcamesine (ANAVEX 2-73) for Alzheimer’s Disease: A Systematic Review

Brimson, S., Thitilertdecha, P., Kumaree, K., & Brimson, J. (2026) · CNS Drugs · doi:10.1007/s40263-026-01327-3

Gantenerumab for Early Alzheimer's Disease: An Updated Systematic Review and Meta‐Analysis

Javed, M. N., Khan, S. M., Mustafa, S., Mujtaba, A., Amin, H., Azhar, N. A., Hameed, A., Zayed, A., Khalid, M., & Hussain, J. M. (2026) · Brain and Behavior · doi:10.1002/brb3.71643

Early Retinal UCHL1 Dysregulation Coupled With Synaptic Loss Reflects Alzheimer's Disease Severity

Rentsendorj, A., Vit, J., Hutton, A., Koronyo, Y., Shahin, S., Robinson, E., Barrón, E., Rodriguez, A., Jallow, O., Sheyn, J., et al. (2026) · Advanced Science · doi:10.1002/advs.202600020

Interpretable machine learning model based on multimodal MRI radiomics for Alzheimer's disease diagnosis

Keranmu, N., Aizezi, D., Pan, X., Yang, L., Liu, Y., & Liu, J. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1876233

Intermittent fasting as a therapeutic strategy in Alzheimer’s disease: Understanding of brain-derived neurotrophic factor modulation

Shrirame, D., Tatode, A., Dabhade, D., Taksande, J., Taksande, B. G., Kakade, O., & Umekar, M. (2026) · Physiology & Behavior · doi:10.1016/j.physbeh.2026.115522

Alzheimer's Disease Modeling

Cole, H. (2024) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.13837389

Alzheimer's Disease: An Overview

G.V. Srivani*, K. V. (2025) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.14651397

Amyloid Beta and Tau: from Physiology to Pathology in Alzheimer’s Disease

Khaledi, S., ایران, گ. ع. ز. د. ع. د. ک. س., Ahmadi, S., & ایران, گ. ع. ز. د. ع. د. ک. س. (2016) · The Neuroscience Journal of Shefaye Khatam · doi:10.18869/acadpub.shefa.4.4.67 · Cited by 14 · see citing works

The pathology, diagnosis and treatment of Alzheimer’s disease

Zheng, J. (2023) · Theoretical and Natural Science · doi:10.54254/2753-8818/20/20230741

Alzheimer’s Disease

Ye, Q. (2022) · Advances in Social Science, Education and Humanities Research/Advances in social science, education and humanities research · doi:10.2991/assehr.k.220504.328